Reply: The Hepa 1-6 may not be suitable for use in hepatocellular carcinoma models to explore responses to drug therapy

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)E125-E126
JournalHepatology
Volume79
Issue number4
DOIs
StatePublished - Apr 2024

ASJC Scopus subject areas

  • Hepatology

Cite this